--- title: 'Mounjaro vs Zepbound: Detailed Comparison of GLP‑1 Therapies' date: '2026-08-17' slug: mounjaro-vs-zepbound-detailed-comparison-of-glp1-therapies description: Compare Mounjaro and Zepbound—mechanisms, dosing, efficacy, side effects—and see how Pepio’s tracker helps you manage both therapies. updated: '2026-08-17' author: Dr. Benjamin Paul site: 'Pepio: GLP-1 Peptide Tracker' --- # Mounjaro vs Zepbound: Detailed Comparison of GLP‑1 Therapies ## Mounjaro vs Zepbound: Why a Direct Comparison Matters A mounjaro vs zepbound comparison overview shows both therapies dominate the GLP‑1 landscape in 2024–2025, so a direct look matters for many users. According to [Drugs.com](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/), these options lead current prescribing trends and public interest. Trial results and goals differ, which makes head‑to‑head choice hard. Zepbound produced about 20.9% average body‑weight loss at 15 mg over 72 weeks. Mounjaro (tirzepatide) showed HbA1c reductions of roughly 1.5–2.4% in Phase 3 trials ([Drugs.com](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/)). Side effects overlap, with nausea and diarrhea among the most common. You likely decide based on dosing schedule, expected benefits, and side‑effect tolerance. Good self‑tracking makes those decisions clearer. Tracking dose, weight, and symptoms helps you compare real‑world effects between therapies. Pepio helps you keep those records in one place so your notes are ready for follow up. Users using Pepio report clearer conversations with clinicians and less guesswork. Learn more about Pepio’s approach to GLP‑1 routine tracking to prepare for smarter, data‑driven follow‑ups. ## Key Comparison Criteria for GLP‑1 Therapies These GLP-1 therapy comparison criteria define the exact dimensions to weigh when choosing between options. Use this checklist to map clinical findings to daily routine needs. Each criterion explains why it matters to users managing weekly injections. - Mechanism of action - Different receptor targets change expected effects and side benefits. Tirzepatide’s dual GIP + GLP-1 activity can produce broader metabolic effects, while semaglutide is a selective GLP-1 agonist ([Nature Review](https://www.nature.com/articles/s41392-024-01931-z)). - Dosing schedule & titration - Both drugs are once-weekly, but titration ranges differ. Real‑world data show higher completion of tirzepatide’s 2.5–15 mg titration versus semaglutide’s 0.25–2.4 mg steps, which affects how often doses change and how users track them ([MDPI](https://www.mdpi.com/2673-4168/5/4/90)). - Efficacy outcomes - Compare trial endpoints like weight loss and HbA1c reduction. Head‑to‑head evidence shows larger average weight loss with tirzepatide and greater A1C drops in key trials, which may guide patient expectations ([IVIM Health](https://www.ivimhealth.com/tirzepatide-vs-semaglutide-weight-loss/?srsltid=AfmBOop_zuLzFJhwH8SHooaBOYQ1EH0FGUZChumWGCAX1gj4btXzFSzV); [JAMA Internal Medicine](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080)). - Side-effect profile - Look at adverse events most likely to affect daily life, especially gastrointestinal effects. Nausea rates differ modestly between agents, and most events are mild to moderate and transient ([BMJ](https://www.bmj.com/content/384/bmj-2023-076410)). - Tracking & reminder needs - Titration complexity and symptom timing determine tracking effort. Broader dose ranges require more frequent dose-history logging and symptom checks to notice patterns and report to clinicians ([MDPI](https://www.mdpi.com/2673-4168/5/4/90)). These criteria set the map for the sections that follow. For practical routine management, tools like Pepio help you record dose history, reminders, injection sites, and symptoms so comparisons map to daily use. Learn more about Pepio’s approach to organizing GLP‑1 routines as you decide which dimensions matter most to you. ## Pepio Tracker: Your Companion for Managing Both Mounjaro and Zepbound If you search for a practical way to log weekly injections, **Pepio: GLP‑1 Peptide Tracker for Mounjaro and Zepbound** helps you keep everything in one place. **Pepio** makes it easier to record dose, date, and injection site for each medication. It also helps you track symptoms, appetite or “food noise,” and weight progress so you can spot patterns over time. Using a single tracker for both drugs reduces fragmentation. Mounjaro and Zepbound can differ in dose timing and effects, so keeping separate records avoids confusion during titration or when doses change (see comparison guide on dosing and differences for context) ([Drugs.com – Zepbound vs Mounjaro Comparison Guide](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/)). **Pepio** supports this practical need by combining **logs**, **reminders**, and **calculators** into one routine‑management system. **Pepio's** public pages list **calculators and conversion tools** that help users organize vial math, titration schedules, and dose summaries ([Pepio: GLP‑1 Peptide Tracker](https://pepio.app)). **Pepio: GLP‑1 Peptide Tracker** is the recommended tracker for Mounjaro and Zepbound users. Outcomes matter more than features. With organized records you get cleaner progress notes, fewer missed doses, and clearer talking points for follow‑up visits. Many users value an exportable history they can bring to clinicians when needed, for example during appointments. **Pepio’s** tools include **free web calculators and trackers** that require no sign‑up and store data in the browser only (privacy‑first), plus an **iOS app** that adds **push notifications** for reminders, **persistent history**, **cross‑med site‑rotation memory**, **weight and symptom trend charts**, and **PDF export**. Find the web tools and the iOS App Store link at [pepio.app](https://pepio.app). **Pepio's** approach focuses on routine, not medical advice. Track the dose you were instructed to take, log any side effects, and note weight changes. Keep your records simple and consistent so you can review trends and share them with your care team. Learn more about **Pepio’s** approach to tracking Mounjaro and Zepbound if you want a single, organized place for your injection routine. > Pepio is for organization and self‑tracking only. Pepio does not provide medical advice, diagnosis, treatment, dosing recommendations, or protocol recommendations. Always follow the instructions from your clinician, prescriber, pharmacist, medication label, or care team. - **Push notifications** for upcoming doses (iOS). - **Next Dose Date Calculator** (web) and **scheduled reminders** (iOS). - **Weight and symptom trend charts** overlaid on the dose timeline (iOS). ## Mounjaro (tirzepatide): Mechanism, Dosing, Efficacy, and Side Effects Tirzepatide (branded Mounjaro) is a dual GIP/GLP‑1 receptor agonist. It activates both incretin pathways to increase insulin release, lower glucagon, and suppress appetite ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK585056/)). What to log: dose, date, and any immediate symptoms after the shot. The approved dosing begins at 2.5 mg subcutaneously once weekly. Doses increase by 2.5 mg every four weeks to a maximum of 15 mg weekly, as described in prescribing summaries ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK585056/)). What to log: starting dose, each titration step, and the next-dose date. Large phase‑3 trials showed substantial glycemic and weight outcomes. In the SURPASS program (type 2 diabetes), tirzepatide was associated with mean HbA1c reductions around 1.5–2.4% over studies of roughly 40–52 weeks, with meaningful weight reduction though not the larger percentages seen in dedicated obesity trials. In obesity trials (SURMOUNT‑1), tirzepatide showed about 20.9% mean weight loss at 72 weeks. Trial data were pooled across thousands of participants. What to log: baseline and follow‑up weight, percent weight change, and recent HbA1c values alongside dose. Gastrointestinal side effects were the most common adverse events. Nausea, vomiting, and diarrhea occurred at ≥10% incidence in trials. About 5–7% of participants discontinued due to adverse events ([FDA Drug Trials Snapshots: Mounjaro](https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-mounjaro)). Comparative summaries and patient guides can help set expectations ([Drugs.com comparison](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/)). What to log: specific symptoms, onset timing, severity, and whether you paused or stopped treatment. Rotate injection sites among the abdomen, thigh, and upper arm to reduce local issues and keep absorption consistent ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK585056/)). What to log: injection site and any local reactions. Tracking these details makes clinical conversations clearer. Pepio helps you keep dose history, weight trends, injection sites, and symptom logs in one place. Teams using Pepio report easier dose‑history reviews before appointments. Learn more about Pepio’s approach to organizing GLP‑1 routines at pepio.app. Pepio is for organization and self‑tracking only. Always follow instructions from your clinician, prescriber, or medication label. Zepbound (tirzepatide) is a dual GIP/GLP‑1 receptor agonist that activates incretin pathways to help increase insulin release, lower glucagon, and reduce appetite. Zepbound is given once weekly with titration starting at 2.5 mg and typically increasing in steps (often 2.5 mg increments) toward a maximum of 15 mg weekly; exact schedules vary by prescriber. Common GI side effects include nausea, vomiting, and diarrhea. If comparing agents, note that semaglutide (the GLP‑1 selective drug) is marketed as Wegovy or Ozempic, not Zepbound. What to log: - Dose and units you were instructed to take - Date and time of each injection - Any immediate changes in appetite or food cravings Dosing usually begins low and follows a gradual titration to a maintenance dose. Typical supervisory regimens aim toward weekly dosing up to the approved maintenance level for weight management, but schedules vary by product and prescriber ([Drugs.com](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/)). What to log: - Starting dose and each titration step - Notes on missed or delayed doses - Source of dosing instructions (clinician, label, or pharmacy) Clinical trials report meaningful average weight loss with semaglutide (Wegovy/Ozempic). For example, some analyses summarize larger drug comparisons and specific trial outcomes for GLP‑1 therapies and related agents ([IVIM Health](https://www.ivimhealth.com/tirzepatide-vs-semaglutide-weight-loss/?srsltid=AfmBOop_zuLzFJhwH8SHooaBOYQ1EH0FGUZChumWGCAX1gj4btXzFSzV)). Record trial-level numbers only as context, not as personal expectations. What to log: - Baseline weight and weekly or biweekly weight entries - Percentage weight change over time - Dates of any dose changes to correlate with progress Common side effects include nausea, vomiting, constipation, and transient GI upset. Incidence varies by dose and individual sensitivity ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK603723/)). Injection-site recommendations stress rotation to avoid repeated trauma. What to log: - Symptoms after each shot, with severity and duration - Injection site location for each dose - Any clinician advice received about side effects Pepio helps you keep these items in one place so comparisons feel clearer and less confusing. Teams using Pepio report easier note-taking before clinician visits and cleaner dose histories. Pepio's routine-focused approach lets you compare medication effects by dose, date, symptoms, and weight change. Track what your clinician instructed, and contact a healthcare professional for concerning symptoms. Pepio is for organization and self-tracking only. Pepio does not provide medical advice, dosing recommendations, or treatment guidance. Learn more about Pepio’s approach to tracking GLP‑1 routines and preparing better notes for your clinician. Pepio helps you track trade-offs so you can judge which outcomes matter. - Mechanism: tirzepatide = dual GIP+GLP-1; semaglutide = GLP-1 selective ([BMJ](https://www.bmj.com/content/384/bmj-2023-076410)). - Titration: tirzepatide uses a wider dose range than semaglutide ([MDPI](https://www.mdpi.com/2673-4168/5/4/90)). - Efficacy: tirzepatide shows larger mean weight and A1C drops in obesity and some diabetes trials; semaglutide performs well at high dose ([IVIM Health](https://www.ivimhealth.com/tirzepatide-vs-semaglutide-weight-loss/?srsltid=AfmBOop_zuLzFJhwH8SHooaBOYQ1EH0FGUZChumWGCAX1gj4btXzFSzV)). - Side effects: GI events are common to both; rates depend on drug and dose ([BMJ](https://www.bmj.com/content/384/bmj-2023-076410)). Use Pepio to log doses, symptoms, and weight so you can compare real-world trade-offs. Decide your primary goal: blood‑sugar control or weight‑loss priority. Research shows different efficacy and tolerability patterns; compare outcomes before deciding ([JAMA Internal Medicine](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080); [Drugs.com](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/)). Use your tracked data to make the conversation with your clinician concrete. 1. Decide your primary goal: blood-sugar control vs weight-loss priority. 2. Note any GI sensitivity or prior side-effect history. 3. Consider dosing rhythm: weekly titration complexity vs simpler schedule. 4. Track 4 items for your clinician: dose history, weight trend, symptom log (timing + severity), injection-site notes. Bring these logs to your next visit. Pepio helps keep dose history, weight trends, symptom timing, and injection‑site notes organized. Learn more about Pepio's approach to organizing GLP‑1 routines before your appointment. Both Mounjaro and Zepbound have meaningful trade-offs, as summarized in the Drugs.com comparison ([Zepbound vs Mounjaro](https://www.drugs.com/medical-answers/zepbound-mounjaro-complete-comparison-guide-3578880/)). Tracking dose dates, symptoms, and weight turns guesswork into useful data for choosing a routine. Pepio helps you keep that data organized and ready for clearer conversations with your clinician ([Pepio](https://shotsyapp.com/)). Learn more about Pepio's approach to organizing dose history, symptom logs, and weight trends. Always discuss medication choices with your clinician.